I. Important Notes
This semi-annual report summary is derived from the full semi-annual report. To fully understand the company's operating results, financial position, and future development plans, investors should carefully read the full semi-annual report on the media designated by the China Securities Regulatory Commission.
All directors attended the board meeting to review this report.
Non-standard audit opinion:
Not applicable
Profit distribution plan or capital reserve conversion plan for the reporting period reviewed by the Board of Directors:
The company does not plan to distribute cash dividends, issue bonus shares, or convert capital reserves into share capital.
Preferred share profit distribution plan for the reporting period approved by the Board of Directors:
II. Company Profile
1. Company Overview
| Item | Details |
|---|---|
| Stock Abbreviation | Jiheng Pharmaceutical |
| Stock Code | 002742 |
| Stock Exchange | Shenzhen Stock Exchange |
| Former Stock Abbreviation | Sansheng Shares |
| Contact Information | Board Secretary | Securities Affairs Representative |
|---|---|---|
| Name | Zhang Xiao | [blank] |
| Office Address | No. 19-2, Yunquan Road, Tiansheng Street, Beibei District, Chongqing | [blank] |
| Telephone | 023-68239069 | [blank] |
| ir@cqjhgf.com | [blank] |
2. Key Accounting Data and Financial Indicators
Whether the company needs to retrospectively adjust or restate accounting data for previous years:
No